Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

HHV-6-positivity in diseases with demyelination.

Pietiläinen-Nicklén J, Virtanen JO, Uotila L, Salonen O, Färkkilä M, Koskiniemi M.

J Clin Virol. 2014 Oct;61(2):216-9. doi: 10.1016/j.jcv.2014.07.006. Epub 2014 Jul 21.

PMID:
25088617
2.

Human parechovirus seroprevalence in Finland and the Netherlands.

Westerhuis B, Kolehmainen P, Benschop K, Nurminen N, Koen G, Koskiniemi M, Simell O, Knip M, Hyöty H, Wolthers K, Tauriainen S.

J Clin Virol. 2013 Sep;58(1):211-5. doi: 10.1016/j.jcv.2013.06.036. Epub 2013 Jul 23.

PMID:
23891146
3.

First two cases of neonatal human parechovirus 4 infection with manifestation of suspected sepsis, Finland.

Jääskeläinen AJ, Kolehmainen P, Kallio-Kokko H, Nieminen T, Koskiniemi M, Tauriainen S, Lappalainen M.

J Clin Virol. 2013 Sep;58(1):328-30. doi: 10.1016/j.jcv.2013.06.010. Epub 2013 Jul 15.

PMID:
23867007
4.

Human parechovirus and the risk of type 1 diabetes.

Kolehmainen P, Koskiniemi M, Oikarinen S, Veijola R, Simell O, Ilonen J, Knip M, Hyöty H, Tauriainen S.

J Med Virol. 2013 Sep;85(9):1619-23. doi: 10.1002/jmv.23659.

PMID:
23852688
5.

Human parechoviruses are frequently detected in stool of healthy Finnish children.

Kolehmainen P, Oikarinen S, Koskiniemi M, Simell O, Ilonen J, Knip M, Hyöty H, Tauriainen S.

J Clin Virol. 2012 Jun;54(2):156-61. doi: 10.1016/j.jcv.2012.02.006. Epub 2012 Mar 8.

PMID:
22406272
6.

ADEM and virus infection.

Pietiläinen-Nicklén J, Virtanen O, Kolehmainen P, Uotila L, Salonen O, Lappalainen M, Färkkilä M, Koskiniemi M.

J Clin Virol. 2012 Jan;53(1):2-5. doi: 10.1016/j.jcv.2011.10.015. Epub 2011 Nov 22. No abstract available.

PMID:
22112626
7.

Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid.

Virtanen JO, Pietiläinen-Nicklén J, Uotila L, Färkkilä M, Vaheri A, Koskiniemi M.

J Neuroimmunol. 2011 Aug 15;237(1-2):93-7. doi: 10.1016/j.jneuroim.2011.06.012. Epub 2011 Jul 20.

PMID:
21767883
8.

Viral meningoencephalitis: a review of diagnostic methods and guidelines for management.

Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PG.

Eur J Neurol. 2010 Aug;17(8):999-e57. doi: 10.1111/j.1468-1331.2010.02970.x. Epub 2010 Mar 3. Review.

PMID:
20236175
9.

HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis.

Pietiläinen J, Virtanen JO, Uotila L, Salonen O, Koskiniemi M, Färkkilä M.

Eur J Neurol. 2010 Mar;17(3):506-9. doi: 10.1111/j.1468-1331.2009.02718.x. Epub 2009 Jun 29.

PMID:
19566903
10.

Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes.

Loparev VN, Rubtcova EN, Bostik V, Tzaneva V, Sauerbrei A, Robo A, Sattler-Dornbacher E, Hanovcova I, Stepanova V, Splino M, Eremin V, Koskiniemi M, Vankova OE, Schmid DS.

Virology. 2009 Jan 20;383(2):216-25. doi: 10.1016/j.virol.2008.10.026. Epub 2008 Nov 20.

11.

Confirmed primary HHV-6 infection in children with suspected encephalitis.

Virtanen JO, Herrgård E, Valmari P, Ahlqvist J, Fogdell-Hahn A, Vaheri A, Koskiniemi M.

Neuropediatrics. 2007 Dec;38(6):292-7. doi: 10.1055/s-2008-1065357.

PMID:
18461505
12.

IgM and avidity of IgG antibodies in primary HHV-6 infections.

Salonen MJ, Vaheri A, Koskiniemi M.

Scand J Infect Dis. 2008;40(5):420-3. doi: 10.1080/00365540701747119.

PMID:
18418803
13.

Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications.

Virtanen JO, Färkkilä M, Multanen J, Uotila L, Jääskeläinen AJ, Vaheri A, Koskiniemi M.

J Neurovirol. 2007 Aug;13(4):347-52.

PMID:
17849318
14.

Primary human herpesvirus-6 infection in the central nervous system can cause severe disease.

Mannonen L, Herrgård E, Valmari P, Rautiainen P, Uotila K, Aine MR, Karttunen-Lewandowski P, Sankala J, Wallden T, Koskiniemi M.

Pediatr Neurol. 2007 Sep;37(3):186-91.

PMID:
17765806
15.

Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland.

Koskiniemi M, Lappalainen M, Schmid DS, Rubtcova E, Loparev VN.

Clin Vaccine Immunol. 2007 Sep;14(9):1057-61. Epub 2007 Jul 11.

16.

Herpesvirus 6:n aiheuttamat infektiot.

Salonen M, Koskiniemi M, Kinnunen E, Aine MR, Junttila O, Linnavuori K, Vaheri A.

Duodecim. 2006;122(13):1607-11. Finnish. No abstract available.

PMID:
17091810
17.

Multiplex-PCR and oligonucleotide microarray for detection of eight different herpesviruses from clinical specimens.

Jääskeläinen AJ, Piiparinen H, Lappalainen M, Koskiniemi M, Vaheri A.

J Clin Virol. 2006 Oct;37(2):83-90. Epub 2006 Jul 26.

PMID:
16872894
18.

Plasminogen activators and their inhibitors in human saliva and salivary gland tissue.

Virtanen OJ, Sirén V, Multanen J, Färkkilä M, Leivo I, Vaheri A, Koskiniemi M.

Eur J Oral Sci. 2006 Feb;114(1):22-6.

PMID:
16460337
19.

Viral encephalitis: a review of diagnostic methods and guidelines for management.

Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PG.

Eur J Neurol. 2005 May;12(5):331-43. Review.

PMID:
15804262
20.

Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue.

Virtanen JO, Zabriskie JB, Sirén V, Friedman JE, Lyons MJ, Edgar M, Vaheri A, Koskiniemi M.

Med Sci Monit. 2005 Mar;11(3):BR84-7.

PMID:
15735559
21.

Varicella zoster and Borrelia burgdorferi are the main agents associated with facial paresis, especially in children.

Jäämaa S, Salonen M, Seppälä I, Piiparinen H, Sarna S, Koskiniemi M.

J Clin Virol. 2003 Jul;27(2):146-51.

PMID:
12829036
22.

Viral infections in neonates with seizures.

Mustonen K, Mustakangas P, Uotila L, Muir P, Koskiniemi M.

J Perinat Med. 2003;31(1):75-80.

PMID:
12661148
23.

CSF findings in neonates with seizures; infectious and noninfectious.

Mustonen K, Uotila L, Laitinen R, Koskiniemi M.

J Perinat Med. 2003;31(1):69-74.

PMID:
12661147
24.

Acute central nervous system complications in varicella zoster virus infections.

Koskiniemi M, Piiparinen H, Rantalaiho T, Eränkö P, Färkkilä M, Räihä K, Salonen EM, Ukkonen P, Vaheri A.

J Clin Virol. 2002 Dec;25(3):293-301.

PMID:
12423693
25.

Tissue plasminogen activator as a key effector in neurobiology and neuropathology.

Teesalu T, Kulla A, Asser T, Koskiniemi M, Vaheri A.

Biochem Soc Trans. 2002 Apr;30(2):183-9. Review.

PMID:
12023848
26.

Antibody status to HHV-6 in children with leukaemia.

Salonen MJ, Siimes MA, Salonen EM, Vaheri A, Koskiniemi M.

Leukemia. 2002 Apr;16(4):716-9.

27.

Chlamydia trachomatis infection in mothers with preterm delivery and in their newborn infants.

Gencay M, Koskiniemi M, Fellman V, Ammala P, Vaheri A, Puolakkainen M.

APMIS. 2001 Sep;109(9):636-40.

PMID:
11878718
28.

[Gene amplification methods in viral diagnostics].

Lappalainen M, Söderlund M, Piiparinen H, Puolakkainen M, Mannonen L, Suni J, von Bonsdorff CH, Koskiniemi M, Hyypiä T, Vaheri A, Hedman K.

Duodecim. 1999;115(9):1031-6. Review. Finnish. No abstract available.

PMID:
11877817
29.

Infections of the central nervous system of suspected viral origin: a collaborative study from Finland.

Koskiniemi M, Rantalaiho T, Piiparinen H, von Bonsdorff CH, Färkkilä M, Järvinen A, Kinnunen E, Koskiniemi S, Mannonen L, Muttilainen M, Linnavuori K, Porras J, Puolakkainen M, Räihä K, Salonen EM, Ukkonen P, Vaheri A, Valtonen V; Study Group.

J Neurovirol. 2001 Oct;7(5):400-8.

PMID:
11582512
30.

Congenital varicella-zoster virus infection after maternal subclinical infection: clinical and neuropathological findings.

Mustonen K, Mustakangas P, Valanne L, Professor MH, Koskiniemi M.

J Perinatol. 2001 Mar;21(2):141-6. Review.

31.

Acute encephalitis from 1967 to 1991.

Rantalaiho T, Färkkilä M, Vaheri A, Koskiniemi M.

J Neurol Sci. 2001 Mar 1;184(2):169-77.

PMID:
11239952
32.

A major role of viruses in convulsive status epilepticus in children: a prospective study of 22 children.

Juntunen A, Herrgård E, Mannonen L, Korppi M, Linnavuori K, Vaheri A, Koskiniemi M.

Eur J Pediatr. 2001 Jan;160(1):37-42.

PMID:
11195016
33.

Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery.

Gencay M, Koskiniemi M, Ammälä P, Fellman V, Närvänen A, Wahlström T, Vaheri A, Puolakkainen M.

APMIS. 2000 Sep;108(9):584-8.

PMID:
11110046
34.

Human herpesvirus-6 associated encephalitis with subsequent infantile spasms and cerebellar astrocytoma.

Rantala H, Mannonen L, Ahtiluoto S, Linnavuori K, Herva R, Vaheri A, Koskiniemi M.

Dev Med Child Neurol. 2000 Jun;42(6):418-21.

35.

Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study.

Mustakangas P, Sarna S, Ammälä P, Muttilainen M, Koskela P, Koskiniemi M.

Int J Epidemiol. 2000 Jun;29(3):587-91.

PMID:
10869335
36.

In situ hybridization detection of human herpesvirus 6 in brain tissue from fatal encephalitis.

Ahtiluoto S, Mannonen L, Paetau A, Vaheri A, Koskiniemi M, Rautiainen P, Muttilainen M.

Pediatrics. 2000 Feb;105(2):431-3.

PMID:
10654970
37.
38.

The association of the human herpesvirus-6 and MS.

Friedman JE, Lyons MJ, Cu G, Ablashl DV, Whitman JE, Edgar M, Koskiniemi M, Vaheri A, Zabriskie JB.

Mult Scler. 1999 Oct;5(5):355-62.

PMID:
10516780
39.

Progressive myoclonus epilepsy of Unverricht-Lundborg type.

Lehesjoki AE, Koskiniemi M.

Epilepsia. 1999;40 Suppl 3:23-8. Review.

40.

Tissue plasminogen activator gene expression in multiple sclerosis brain tissue.

Akenami FO, Sirén V, Wessman M, Koskiniemi M, Vaheri A.

J Neurol Sci. 1999 May 1;165(1):71-6.

PMID:
10426151
41.

Clinical features and genetics of progressive myoclonus epilepsy of the Univerricht-Lundborg type.

Lehesjoki AE, Koskiniemi M.

Ann Med. 1998 Oct;30(5):474-80. Review.

PMID:
9814834
42.

Antibodies to varicella zoster virus in the cerebrospinal fluid of neonates with seizures.

Mustonen K, Mustakangas P, Smeds M, Mannonen L, Uotila L, Vaheri A, Koskiniemi M.

Arch Dis Child Fetal Neonatal Ed. 1998 Jan;78(1):F57-61.

44.

Chlamydia trachomatis detected in human placenta.

Gencay M, Puolakkainen M, Wahlström T, Ammälä P, Mannonen L, Vaheri A, Koskiniemi ML.

J Clin Pathol. 1997 Oct;50(10):852-5.

45.

Epidemiology and prognosis of acute myelitis in Southern Finland.

Färkkilä M, Tiainen T, Koskiniemi M.

J Neurol Sci. 1997 Nov 25;152(2):140-6.

PMID:
9415534
46.

Epidemiology of encephalitis in children. A prospective multicentre study.

Koskiniemi M, Korppi M, Mustonen K, Rantala H, Muttilainen M, Herrgård E, Ukkonen P, Vaheri A.

Eur J Pediatr. 1997 Jul;156(7):541-5.

PMID:
9243237
47.

Seroprevalence and coprevalence of HIV and HBsAg in Nigerian children with/without protein energy malnutrition.

Akenami FO, Koskiniemi M, Ekanem EE, Bolarin DM, Vaheri A.

Acta Trop. 1997 Apr 15;64(3-4):167-74.

PMID:
9107364
48.

Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1.

Virtaneva K, D'Amato E, Miao J, Koskiniemi M, Norio R, Avanzini G, Franceschetti S, Michelucci R, Tassinari CA, Omer S, Pennacchio LA, Myers RM, Dieguez-Lucena JL, Krahe R, de la Chapelle A, Lehesjoki AE.

Nat Genet. 1997 Apr;15(4):393-6.

PMID:
9090386
49.

Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.

Akenami FO, Koskiniemi M, Färkkilä M, Vaheri A.

J Clin Pathol. 1997 Feb;50(2):157-60.

50.

Assessment of plasma fibronectin in malnourished Nigerian children.

Akenami FO, Koskiniemi M, Siimes MA, Ekanem EE, Bolarin DM, Vaheri A.

J Pediatr Gastroenterol Nutr. 1997 Feb;24(2):183-8.

PMID:
9106105

Supplemental Content

Loading ...
Support Center